583 top medical experts on Mucoepidermoid Carcinoma across 58 countries and 36 U.S. states, including 471 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Mucoepidermoid Carcinoma: A tumor of both low- and high-grade malignancy. The low-grade grow slowly, appear in any age group, and are readily cured by excision. The high-grade behave aggressively, widely infiltrate the salivary gland and produce lymph node and distant metastases. Mucoepidermoid carcinomas account for about 21% of the malignant tumors of the parotid gland and 10% of the sublingual gland. They are the most common malignant tumor of the parotid. (From DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p575; Holland et al., Cancer Medicine, 3d ed, p1240)
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Broader Categories (#Experts): Adenocarcinoma (5,212), and Serous Mucinous Cystic Neoplasms (1,447).
  4. Clinical Trials ClinicalTrials.gov : at least 23 including 1 Active, 16 Completed, 2 Recruiting


  

        

                    


    Computing Expert Listing ...

);